BERNINI, Franco
 Distribuzione geografica
Continente #
NA - Nord America 8.703
EU - Europa 7.083
AS - Asia 4.012
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 5
OC - Oceania 3
Totale 19.843
Nazione #
US - Stati Uniti d'America 8.540
CN - Cina 2.728
IE - Irlanda 1.632
FI - Finlandia 1.183
SE - Svezia 1.138
DE - Germania 906
UA - Ucraina 884
IT - Italia 799
SG - Singapore 673
TR - Turchia 499
CA - Canada 158
FR - Francia 143
GB - Regno Unito 124
AT - Austria 81
BE - Belgio 46
CZ - Repubblica Ceca 44
IN - India 43
NL - Olanda 33
HK - Hong Kong 18
ES - Italia 17
CI - Costa d'Avorio 15
EU - Europa 15
IL - Israele 11
JP - Giappone 10
PL - Polonia 10
RO - Romania 10
ID - Indonesia 7
TW - Taiwan 7
HU - Ungheria 6
IR - Iran 4
LU - Lussemburgo 4
MX - Messico 4
RS - Serbia 4
CH - Svizzera 3
CM - Camerun 3
PT - Portogallo 3
AU - Australia 2
BG - Bulgaria 2
BR - Brasile 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
KR - Corea 2
KZ - Kazakistan 2
NG - Nigeria 2
PK - Pakistan 2
SA - Arabia Saudita 2
AR - Argentina 1
CL - Cile 1
EE - Estonia 1
HR - Croazia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
RU - Federazione Russa 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VN - Vietnam 1
Totale 19.843
Città #
Dublin 1.632
Chandler 1.550
Jacksonville 1.114
Beijing 751
Nanjing 507
Ashburn 503
Dearborn 498
Boardman 497
Izmir 484
Singapore 455
Princeton 388
Ann Arbor 376
Wilmington 260
Parma 249
New York 237
San Mateo 234
Bremen 230
Shenyang 150
Toronto 142
Shanghai 140
Nanchang 135
Hebei 134
Helsinki 118
Kunming 116
Hefei 104
Jinan 94
Des Moines 91
Seattle 85
Santa Clara 84
Jiaxing 77
Vienna 75
Woodbridge 74
Grafing 73
Tianjin 72
Changsha 62
Marseille 59
Norwalk 57
Los Angeles 48
Guangzhou 47
Brussels 43
Chicago 38
Houston 35
Zhengzhou 35
Pune 34
Milan 31
Fremont 29
Brno 28
Hangzhou 26
Munich 26
Taiyuan 22
Düsseldorf 21
Bologna 20
Dallas 17
Haikou 17
Rockville 17
Ningbo 16
Abidjan 15
Modena 15
Rome 14
Kocaeli 13
Taizhou 13
Auburn Hills 12
Borås 12
Falls Church 12
Bari 11
Chengdu 11
Fuzhou 11
Xian 11
Shenzhen 10
Tel Aviv 10
Madrid 9
Simi Valley 9
Warsaw 9
Hong Kong 8
Washington 8
Florence 7
Paris 7
Redmond 7
Redwood City 7
San Giuliano Milanese 7
Ardea 6
Budapest 6
Fairfield 6
Frankfurt am Main 6
Huizen 6
Naples 6
Palermo 6
Piacenza 6
Sant'ilario D'enza 6
Scottsdale 6
Shaoxing 6
Turin 6
Wenzhou 6
Wuhan 6
Abbiategrasso 5
Albignasego 5
Castello Molina di Fiemme 5
Edinburgh 5
Formigine 5
Magdeburg 5
Totale 12.819
Nome #
The adaptation of lipid profile of human fibroblasts to alginate 2D films and 3D printed scaffolds 145
Three-Dimensional (3D) Printed Silver Nanoparticles/Alginate/Nanocrystalline Cellulose Hydrogels: Study of the Antimicrobial and Cytotoxicity Efficacy 129
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC 122
Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis 104
ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease 102
New MDR1 inhibitors for overcoming multidrug resistance 95
CHARACTERIZATION OF THREE KINDRED WITH FAMILIAL COMBINED HYPOLIPIDEMIA DUE TO LOSS OF FUNCTION MUTATIONS OF ANGPTL3 91
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 89
Effetto delle statine sull’efflusso ABCA1 in macrofagi e cellule epatiche 87
A Short Term Administration of Cyclosporine A to Mice Inhibits the Reverse Cholesterol Transport from Macrophages 87
Assessment of Cholesterol Efflux Potential of High-Density Lipoprotein after Treatment with Niacin Extended-Release or Fenofibrate 85
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM DIABETIC PATIENTS: CLINICAL APPLICATIONS 85
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 84
Attivita' del Probucolo nell'inibire l'efflusso lipidico cellulare ABCA1-mediato 84
ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects 84
Ruolo dell’apolipoproteine E nell’efflusso cellulare di colesterolo 83
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 83
Advance diagnostic support in lipidology project: role for phenotipic and functional evaluation of lipoproteins in dyslipidemias 82
Cholesterol efflux capacity of sera from subjects with LCAT deficiency 81
Lercanidipine Reduces Free Cholesterol-Induced Cytotoxicity 81
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 81
Highly defined 3D printed chitosan scaffolds featuring improved cell growth 81
Effect of carvedilol on cholesterol esterification and nitric oxide synthesis in cultured macrophages 80
Role of Apolipoprotein E in cellular cholesterol efflux 79
Antiatherogenic effects of ellagic acid and urolithins in vitro 79
Functional pasta consumption in healthy volunteers modulates ABCG1-mediated cholesterol efflux capacity of HDL 79
Dislipidemia diabetica e spessore medio-intimale, ruolo del trasporto inverso del colesterolo. 79
SERUM CHOLESTEROL EFFLUX CAPACITY INVERSELY CORRELATES WITH ARTERIAL STIFFNESS IN HEALTHY SUBJECTS 79
Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases 79
Natural anti-endothelial cell antibodies (AECA) 78
Effetto degli agonisti LXR sul trasporto inverso del colesterolo in vivo 78
SERUM CHOLESTEROL EFFLUX CAPACITY INVERSELY CORRELATES WITH ARTERIAL STIFNESS IN HEALTY SUBJECTS 78
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 78
The c-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phopspholipid and cholesterol efflux 77
Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients 77
Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophages 76
ABCA1 MODULATES CELLULAR MIGRATION AND MEMBRANE RUFFLING INDUCED BY FREE CHOLESTEROL IN MACROPHAGES FOAM CELLS 76
Immunoglobulin G inhibit endothelial activation induced by atherogenic stimuli 75
Attivita’ del probucolo nell’inibire l’efflusso lipidico cellulare ABCA1 mediato 74
Pitavastatin Differently Modulates ATP Binding Cassette A1-Mediated Lipid Efflux in Macrophages and Hepatic Cells 74
Cyclosporine a affects the reverse cholesterol transport from macrophages in vivo 74
5,6-diphenylpyridazine derivatives as acyl-Coacholesterol acyltransferase inhibitors 73
Analysis of lipid efflux in fibroblasts from Niemann Pick Type C disease subjects 73
Serum cholesterol efflux capacity and endothelial function in hyperalfalipoproteinemic subjects 72
Lacidipine modulates the secretion of matrix metalloproteinase-9 by human macrophages 71
Opposite effects of moderate and excess alcohol consumption on the atheroprotective process of the reverse cholesterol transport in vivo 71
Immunoglobulins G inhibit endothelial activation induced by atherogenic stimuli 70
LA CICLOSPORINA A INIBISCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI 70
L’ALCALOIDE BERBERINA RIDUCE L’ATTIVITÀ DI ABCA1 NEI MACROFAGI CON UN EFFETTO TRASCRIZIONALE 70
ABCA1 MODULATES CELLULAR MIGRATION AND MEMBRANE RUFFLING INDUCED BY FREE CHOLESTEROL IN MACROPHAGES FOAM CELLS 70
Study of 3D-printed chitosan scaffold features after different post-printing gelation processes 70
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G>C mutation in ABCA1 gene 70
Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease 70
Effetto della mutazione dell’enzima LCAT sull’efflusso cellulare di colesterolo 69
Cellular cholesterol efflux pathways: Impact on Intracellular Lipid Trafficking and Methodological Considerations 69
Cellular toxicity of 2,2'N-dicarboxamidodiphenylsulphides with high antimicrobal activity 69
THE THIENOTRIAZOLODIAZEPINE RO 11-1464 INCREASES PLASMA APOA-I AND PROMOTES REVERSE CHOLESTEROL TRANSPORT AND FECAL STEROL EXCRETION IN HUMAN APOA-I TRANSGENIC MICE 69
RUOLO DELLA SFINGOSINA 1-FOSFATO E DEL SUO RECETTORE S1P3 NEL TRASPORTO INVERSO DEL COLESTEROLO 69
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 68
Increased ABCA1-mediated cholesterol efflux potential of sera from ApoAI milano carriers 68
Effetto della Ciclosporina A sul trasporto inverso del colesterolo in vivo 68
Hydrocortisone directly promotes cholesterol accumulation in macrophages. 68
Impaired ATP-binding cassette Transporter AI-mediated Sterols Efflux from Oxidized LDL Loaded Macrophages 67
Fu5AH express functional ABCA1 upon treatment with 22OH-cholesterol and cis-9 retinoic acid 67
Natural anti-endothelial cell antibodies (AECA) 67
Effect of an innovative pasta enriched with bioactive components and functional probiotics on HDL cholesterol efflux capacity 67
Biocompatible 3d printed chitosan-based scaffolds containing α-tocopherol showing antioxidant and antimicrobial activity 67
Depletion of Pre-{beta}-high Density Lipoprotein by Human Chymase Impairs ATP-binding Cassette Transporter A1- but Not Scavenger Receptor Class B Type I-mediated Lipid Efflux to High Density Lipoprotein 67
Effect of vitamin D deficiency and replacement on serum HDL cholesterol efflux capacity in premenopausal women 67
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus 66
Effects of moderate and excess alcohol consumption on the reverse cholesterol transport in vivo 66
Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells 66
The LXR agonist T0901317 promotes the reverse cholesterol transport frommacrophages by increasing plasma efflux potential 66
Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion 66
An w-3 polyunsaturated fatty acid concentrate increases plasma HDL2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia 65
Rupture of the Atherosclerotic Plaque. Does a Good Animal Model Exist? 65
Modulation of cholesterol efflux in human THP-I macrophages 65
Cyclosporine A modulates the macrophage reverse cholesterol transport in vivo 64
CAPACITA' DI EFFLUSSO DI COLESTEROLO (CEC): INDICE DI ATTIVITA' ATEROPROTETTIVA DELLE HDL? Cholesterol efflux capacity (CEC): an index of atheroprotective activity of HDL? 64
Alcohol pattern consumption differently affects the efficiency of macrophage reverse cholesterol transport in vivo 64
Device for ocular administration of fluids 64
Pleiotropic Antiatherosclerotic Effect of Lipophilic Calcium Antagonists in Macrophages 63
La Lercanidipina riduce la tossicita' cellulare indotta dall'accumulo di colesterolo libero 63
Cholesterol efflux from oxidized LDL loaded macrophages 63
Dietary Ellagitannin Metabolites Exert Antiatherosclerotic Effects in Vitro 63
Evaluation of HDL cholesterol efflux capacity (CEC) after consumption of an innovative pasta enriched with bioactive components and functional probiotics 63
Investigation on mechanisms of cholesterol efflux in human monocytes/macrophages THP-1 63
Effect of HDL composition and size on cellular cholesterol efflux 63
Pitavastatin modulation of cholesterol efflux and interleukin-6 secretion in endothelial cells 63
LA CICLOSPORINA A RIDUCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI ATTRAVERSO L’INIBIZIONE DELL’ESCREZIONE FECALE 63
Macrophage, But Not Systemic, Apolipoprotein E Is Necessary for Macrophage Reverse Cholesterol Transport In Vivo 63
High density lipoprotein function is reduced in patients affected by genetic or idiopathic hypogonadism. 63
Normal human IgG prevents endothelial cell activation induced by TNFalpha and oxidized low-density lipoprotein atherogenic stimuli 62
The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux 62
A SHORT TERM ADMINISTRATION OF CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO 62
Cholesterol efflux and reverse cholesterol transport 62
Razionale farmacologico e prove di efficacia della combinazione di più nutraceutici ad azione ipocolesterolemizzante 62
Le HDL: lipoproteine antiaterogene 62
In vitro inhibitory effect of lercanidipine on cholesterol accumulation and matrix metalloproteinases secretion by macrophages 61
New insights into the pharmacodynamic and pharmacokinetic properties of statins 61
Totale 7.418
Categoria #
all - tutte 79.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.373 0 0 0 45 339 352 449 73 366 381 111 257
2020/20211.973 31 252 155 35 249 57 225 51 498 59 305 56
2021/20221.594 46 17 13 58 36 95 185 211 92 151 81 609
2022/20236.014 702 447 306 439 738 672 54 332 2.042 42 177 63
2023/20242.168 126 244 66 73 151 603 122 157 49 82 157 338
2024/20251.236 137 454 533 112 0 0 0 0 0 0 0 0
Totale 20.376